The treatment of clopidogrel resistance: Triple antiplatelet therapy and future directions

被引：2
|
作者：
Acikel, Sadik [1 ]
Akdemir, Ramazan [1 ]
Cagirci, Goksel [1 ]
Yesilay, Asuman Bicer [1 ]
Dogan, Mehmet [1 ]
Kilic, Harun [1 ]
机构：
[1] Diskapi Yildirim Beyazit Res & Educ Hosp, Minist Hlth, Dept Cardiol, TR-06110 Ankara, Turkey
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2010年 / 144卷 / 01期
关键词：
Clopidogrel resistance; Cilostazol; Antiplatelet therapy; ACUTE CORONARY SYNDROMES; STENT THROMBOSIS; MYOCARDIAL-INFARCTION; PLATELET ACTIVATION; CLEAR PLATELETS; TRIAL; CILOSTAZOL; INTERVENTION; VARIABILITY; IMPACT;
D O I：
10.1016/j.ijcard.2008.12.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：79 / 82
页数：5
相关论文
共 50 条
  • [1] The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation
    Shim, Chi Young
    Yoon, Se-Jung
    Park, Sungha
    Kim, Jung-Sun
    Choi, Jong Rak
    Ko, Young-Guk
    Choi, Donghoon
    Ha, Jong-Won
    Jang, Yangsoo
    Chung, Namsik
    Shim, Won-Heum
    Cho, Seung-Yun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (03) : 351 - 355
  • [2] Triple antiplatelet therapy for clopidogrel resistance with stent malapposition: a case report
    Ding Feng-hua
    Zhang Qi
    Zhang Rui-yan
    Hu Jian
    Shen Jie
    Zhao Liang-ping
    Du Run
    Zhang Xian
    Shen Wei-feng
    CHINESE MEDICAL JOURNAL, 2009, 122 (18) : 2186 - 2188
  • [3] Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?
    Niazi, Asfandyar K.
    DiNicolantonio, James J.
    Lavie, Carl J.
    O'Keefe, James H.
    Meier, Pascal
    Bangalore, Sripal
    CARDIOLOGY, 2013, 126 (04) : 233 - 243
  • [4] New Directions in Antiplatelet Therapy
    Ferreiro, Jose Luis
    Angiolillo, Dominick J.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (03) : 433 - 445
  • [5] Clopidogrel Resistance: Current Aspects and Future Directions
    Vlachojannis, Georgios J.
    Dimitropoulos, Gerasimos
    Alexopoulos, Dimitrios
    HELLENIC JOURNAL OF CARDIOLOGY, 2011, 52 (03) : 236 - 245
  • [6] No Role for Triple Antiplatelet Therapy?
    Antoniucci, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (03) : 290 - 291
  • [7] Cilostazol-based triple antiplatelet therapy in the era of generic clopidogrel and new potent antiplatelet agents
    Tselepis, Alexandros D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (01) : 51 - 54
  • [8] Clopidogrel Resistance: Identifying and Overcoming a Barrier to Effective Antiplatelet Treatment
    Uchiyama, Shinichiro
    CARDIOVASCULAR THERAPEUTICS, 2011, 29 (06) : E100 - E111
  • [9] The role of genetic factors in clopidogrel antiplatelet therapy
    Cieslewicz, Artur Robert
    Kazmierczak, Ewa
    Jablecka, Anna
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2012, 8 (02): : 126 - 129
  • [10] Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI
    Yang, Tae-Hyun
    Jin, Han-Young
    Choi, Kyu-Nam
    Do, Ungjeong
    Kim, Hyung Jun
    Chung, Sang-Ryul
    Seo, Jeong-Sook
    Jang, Jae-Sik
    Kim, Dae-Kyeong
    Kim, Dong-Soo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 207 - 211
12345